Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Liver Diseases

Free Subscription Articles published in Gut Retrieve available abstracts of 103 articles: HTML format Text format

Single Articles

January 2012
1. KALDENBACH M , Giebeler A, Tschaharganeh DF, Erschfeld S, et al
   Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.
   Gut. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. FERREIRA CN , Rodrigues T, Cortez-Pinto H, Serejo F, et al
   The new definition of acute kidney injury in patients with cirrhosis: a critical look.
   Gut. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
3. TREMOSINI S , Forner A, Boix L, Vilana R, et al
   Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
   Gut. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. RIBERA J , Pauta M, Melgar-Lesmes P, Tugues S, et al
   Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats.
   Gut. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. YE D , Li FY, Lam KS, Li H, et al
   Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
   Gut. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KRAG A , Wiest R, Albillos A, Gluud LL, et al
   The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease.
   Gut. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
7. NEWSOME PN , Allison ME, Andrews PA, Auzinger G, et al
   Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis.
   Gut. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
8. EAPEN CE
   Copper and liver disease.
   Gut. 2012;61:63.
   PubMed     Text format     Related articles   
   
   
   
   
9. STICKEL F , Hampe J
   Genetic determinants of alcoholic liver disease.
   Gut. 2012;61:150-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. RAMAGE JK , Ahmed A, Ardill J, Bax N, et al
    Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).
    Gut. 2012;61:6-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
11. GUR C , Doron S, Kfir-Erenfeld S, Horwitz E, et al
    NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. PAN Q , Ramakrishnaiah V, Henry S, Fouraschen S, et al
    Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. BOCKX I , Verdrengh K, Vander Elst I, van Pelt J, et al
    High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. HENRIKSEN JH , Fuglsang S, Bendtsen F
    Fourier analysis of arterial pulse in patients with advanced cirrhosis indicates reduced wave reflections that may protect against manifest cardiac dysfunction.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
15. BLUM HE
    Gastrointestinal and liver diseases: genetic and epigenetic markers.
    Gut. 2011;60:1630-4.
    PubMed     Text format     Related articles   
    
    
    
    
16. WONG VW , Wong GL, Yip GW, Lo AO, et al
    Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.
    Gut. 2011;60:1721-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. GLEESON D , McFarlane E, Dube A, Elphick DA, et al
    Comments on 'Early features of acute-on-chronic liver failure: a prospective cohort study'.
    Gut. 2011;60:1766.
    PubMed     Text format     Related articles   
    
    
    
    
18. TSUJINO T , Ito Y, Yoshida H, Ikushima S, et al
    Duodenal mass in a patient with weight loss and liver dysfunction. Duodenal and liver sarcoidosis.
    Gut. 2011;60:1659-60.
    PubMed     Text format     Related articles   
    
    
    
    November 2011
19. BADIOLA I , Olaso E, Crende O, Friedman SL, et al
    Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. FRITH J , Fattakhova G, Jones DE, Henderson E, et al
    Cognitive impairment in non-cirrhotic chronic liver disease is unrelated to liver disease severity but associated with ineffective baroreflex function.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
21. TARGHER G , Zoppini G, Day CP
    Risk of all-cause and cardiovascular mortality in patients with chronic liver disease.
    Gut. 2011;60:1602-3.
    PubMed     Text format     Related articles   
    
    
    
    
22. JUBB AM , Hoeflich KP, Haverty PM, Wang J, et al
    Ascl2 and 11p15.5 amplification in colorectal cancer.
    Gut. 2011;60:1606-7.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
23. ZAGOURA DS , Roubelakis MG, Bitsika V, Trohatou O, et al
    Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. LOPES JA , Melo MJ, Costa AC, Raimundo M, et al
    Acute kidney injury and in-hospital mortality in critically ill patients with cirrhosis: a cohort study.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. RAPTIS DA , Fischer MA, Graf R, Nanz D, et al
    MRI: the new reference standard in quantifying hepatic steatosis?
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. TSOCHATZIS EA , Manousou P, Fede G, Dhillon AP, et al
    Validating non-invasive markers of fibrosis: the need for a new histological reference standard.
    Gut. 2011;60:1442-3.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
27. CHEW V , Chen J, Lee D, Loh E, et al
    Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. HALLSWORTH K , Fattakhova G, Hollingsworth KG, Thoma C, et al
    Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss.
    Gut. 2011;60:1278-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. NOUREDDIN M , Kleiner DE, Gharib AM, Bratslavsky G, et al
    To resect or not to resect? That is the question. Telangiectatic adenoma.
    Gut. 2011;60:1177.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
30. RODERFELD M , Rath T, Pasupuleti S, Zimmermann M, et al
    Bone marrow transplantation improves hepatic fibrosis in Abcb4-/- mice via Th1 response and matrix metalloproteinase activity.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. WONG F , Watson H, Gerbes A, Vilstrup H, et al
    Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. ABRAMOVITCH S , Dahan-Bachar L, Sharvit E, Weisman Y, et al
    Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. BAECK C , Wehr A, Karlmark KR, Heymann F, et al
    Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. BRENNDORFER ED , Brass A, Soderholm J, Frelin L, et al
    Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-{gamma} production.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. WESTBROOK RH , Joshi D, Prachalias A
    An 'illuminating' CT.
    Gut. 2011;60:1067.
    PubMed     Text format     Related articles   
    
    
    
    
36. BRUNT EM
    Non-alcoholic fatty liver disease: what's new under the microscope?
    Gut. 2011;60:1152-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. GUL N , Bogels M, Grewal S, van der Meer AJ, et al
    Surgery-induced reactive oxygen species enhance colon carcinoma cell binding by disrupting the liver endothelial cell lining.
    Gut. 2011;60:1076-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
38. HAN G , Qi X, Guo W, Niu J, et al
    Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
39. RESS C , Moschen AR, Sausgruber N, Tschoner A, et al
    The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
    Gut. 2011;60:985-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
40. STEIB CJ
    Kupffer cell activation and portal hypertension.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
41. ZHENG F , Liao YJ, Cai MY, Liu YH, et al
    The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. AGUSTI A , Cauli O, Rodrigo R, Llansola M, et al
    p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. TILG H , Diehl AM
    NAFLD and extrahepatic cancers: have a look at the colon.
    Gut. 2011;60:745-6.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
44. ROSSLE M
    Hyperdynamic circulation and portal hypertension: chicken or egg?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
45. HOLLAND-FISCHER P , Gronbaek H, Sandahl TD, Moestrup SK, et al
    Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. MULLER-LISSNER SA , Fuhrmann E
    A prematurely terminated journey.
    Gut. 2011;60:630.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
47. THURSZ M , Brown A
    Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
48. MOLLER S , Hobolth L, Winkler C, Bendtsen F, et al
    Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. CASTERA L
    Screening the general population for cirrhosis using transient elastography: finding a needle in a haystack?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
50. IBRAHIM AE , Arends MJ, Silva AL, Wyllie AH, et al
    Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression.
    Gut. 2011;60:499-508.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
51. MELGAR-LESMES P , Pauta M, Reichenbach V, Casals G, et al
    Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. LAMERZ R
    Improvement of histological biopsy diagnosis of hepatocellular carcinoma by genomic biomarkers?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
53. BRAILLON A
    Do patients screened for hepatocellular carcinoma die significantly older?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
54. LA MURA V , Reverter JC, Flores-Arroyo A, Raffa S, et al
    Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. HUTCHINSON JM , Davies MH
    The use of clonidine with diuretic therapy in the treatment of refractory ascites in patients with cirrhosis awaiting liver transplantation.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
56. AUERNHAMMER CJ , Goke B
    Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. PASTORE S , Londero M, Cont G, Di Leo G, et al
    Refractory iron-deficiency anaemia in a child with portal cavernoma.
    Gut. 2011;60:317.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
58. LUCA A , Miraglia R, Caruso S, Milazzo M, et al
    Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. WONG VW , Wong GL, Tsang SW, Fan T, et al
    High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. CAI MY , Tong ZT, Zheng F, Liao YJ, et al
    EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. WONG F , Nadim MK, Kellum JA, Salerno F, et al
    Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. MOLEDA L , Trebicka J, Dietrich P, Gabele E, et al
    Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. VENTURELLI S , Berger A, Weiland T, Zimmermann M, et al
    Dual antitumour effect of 5-azacytidine by inducing a breakdown of resistance-mediating factors and epigenetic modulation.
    Gut. 2011;60:156-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
64. KLUWE J , Wongsiriroj N, Troeger JS, Gwak GY, et al
    Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. PAPATHEODORIDIS GV , Manolakopoulos S, Touloumi G, Vourli G, et al
    Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET.Greec
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. MIQUILENA-COLINA ME , Lima-Cabello E, Sanchez-Campos S, Garcia-Mediavilla MV, et al
    Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. EL-SERAG HB , Kramer JR, Chen GJ, Duan Z, et al
    Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. FARGES O , Ferreira N, Dokmak S, Belghiti J, et al
    Changing trends in malignant transformation of hepatocellular adenoma.
    Gut. 2011;60:85-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. POWELL EE , Jonsson JR, Clouston AD
    Not every cell is as it seems: a role for ductular epithelial cells in fibrosis?
    Gut. 2011;60:1-2.
    PubMed     Text format     Related articles   
    
    
    
    
70. BOHM I
    Asteroids in the blood.
    Gut. 2011;60:9.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
71. CARDENAS A , Gines P
    Management of patients with cirrhosis awaiting liver transplantation.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
72. TAGARAM HR , Divittore NA, Barth BM, Kaiser JM, et al
    Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. THALHEIMER U , Burroughs AK
    A case of bleeding oesophageal varices.
    Gut. 2010;59:1616.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
74. BERAZA N , Ofner-Ziegenfuss L, Ehedego H, Boekschoten M, et al
    Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. GRACIA-SANCHO J , Russo L, Garcia-Caldero H, Garcia-Pagan JC, et al
    Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. KALLIS YN , Robson AJ, Fallowfield JA, Thomas HC, et al
    Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. CHEN L , Yuan YF, Li Y, Chan TH, et al
    Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. ROULOT D , Costes JL, Buyck JF, Warzocha U, et al
    Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. JALAN R , Mookerjee RP
    Acute-on-chronic liver failure: an early biopsy is essential?
    Gut. 2010;59:1455-6.
    PubMed     Text format     Related articles   
    
    
    
    
80. KUMARASENA RS , Niriella MA, Kalubowila U, de Silva AP, et al
    Bleeding from oesophageal ulceration induced by endoscopic variceal ligation for primary prophylaxis.
    Gut. 2010;59:1586.
    PubMed     Text format     Related articles   
    
    
    
    
81. KATOONIZADEH A , Laleman W, Verslype C, Wilmer A, et al
    Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study.
    Gut. 2010;59:1561-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
82. HU H , Li Z, Chen J, Wang D, et al
    P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. AMITRANO L , Guardascione MA, Menchise A, Manguso F, et al
    Management of variceal haemorrhage in cirrhosis: the relevance of the risk stratification.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
84. ZHOU H , Huang H, Shi J, Zhao Y, et al
    Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. GOEL A , Ramakrishna B, Zachariah U, Ramachandran J, et al
    How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis?
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
86. MARCHESINI G , Bianchi G
    Metabolic syndrome: relevant for all types of chronic liver diseases?
    Gut. 2010;59:1314-5.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
87. MAO Y , Yang H, Xu H, Lu X, et al
    Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. GONZALEZ-APARICIO M , Alzuguren P, Mauleon I, Medina-Echeverz J, et al
    Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. YANG YY , Lin HC, Lee WP, Chu CJ, et al
    Association of the G-protein and {alpha}2-adrenergic receptor gene and plasma norepinephrine level with clonidine improvement of the effects of diuretics in patients with cirrhosis with refractory ascites: a randomised clinical trial.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. MCPHERSON S , Stewart SF, Henderson E, Burt AD, et al
    Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    Gut. 2010;59:1265-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. PARKES J , Roderick P, Harris S, Day C, et al
    Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.
    Gut. 2010;59:1245-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MEIJER GA
    What makes CRCs metastasise?
    Gut. 2010;59:1164-5.
    PubMed     Text format     Related articles   
    
    
    
    
93. ALTAMIRANO J , Bataller R
    Cigarette smoking and chronic liver diseases.
    Gut. 2010;59:1159-62.
    PubMed     Text format     Related articles   
    
    
    
    August 2010
94. GHITTONI G , Caturelli E, Rossi S
    Synchronous focal liver lesions in a patient with liver cirrhosis: commonplaces may be misleading.
    Gut. 2010;59:1155-6.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
95. YU P , Cheng X, Guo J, Wang X, et al
    Toll-like receptors 2/4 agonists: a potential strategy for preventing invasion and metastasis of hepatocellular carcinoma.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
96. BOOZARI B , Mundt B, Woller N, Struver N, et al
    Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. MUHANNA N , Tair LA, Doron S, Amer J, et al
    Amelioration of hepatic fibrosis by NK cell activation.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. STICKEL F , Hellerbrand C
    Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
99. WONG VW , Wong GL, Choi PC, Chan AW, et al
    Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Gut. 2010;59:969-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. LEE JH , Bae JA, Lee JH, Seo YW, et al
     Glycoprotein 90K, downregulated in advanced colorectal cancer tissues, interacts with CD9/CD82 and suppresses the Wnt/beta-catenin signal via ISGylation of beta-catenin.
     Gut. 2010;59:907-17.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. TEUFEL A , Galle PR
     Collecting evidence for a stem cell hypothesis in HCC.
     Gut. 2010;59:870-1.
     PubMed     Text format     Related articles   
     
     
     
     May 2010
102. STANGE DE , Engel F, Longerich T, Koo BK, et al
     Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.
     Gut. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. NOBILI V , Pinzani M
     Paediatric non-alcoholic fatty liver disease.
     Gut. 2010;59:561-4.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: